Results 161 to 170 of about 816,942 (315)

Molecular imaging predicts trastuzumab‐deruxtecan (T‐DXd) response in head and neck cancer xenograft models

Molecular Oncology, EarlyView.
Trastuzumab‐deruxtecan, a HER2‐targeting antibody‐drug conjugate, shows promising antitumor activity in head and neck squamous cell carcinoma with low HER2 expression. In vitro and in vivo studies demonstrated dose‐dependent cell death and tumor growth reduction in low HER2‐expressing cell lines, which correlated with drug accumulation measured using a
Abdullah Bin Naveed, Lucas Mani, Muhammad Bilal Mirza, Ashtyn McAdoo, Takahito Kondo, Hidenori Tanaka, Nicole Meeks, Eben Rosenthal, Marisa Hom   +8 more
wiley   +1 more source

Cervical Cancer Screening After Menopause. [PDF]

Healthcare (Basel)
Tung HJ, Schwarzschild G, Gopep N, Yeh MC.   +3 more
europepmc   +1 more source

The predictive value of positive test results in screening for breast cancer by mammography in the Nijmegen programme

, 1987
PHM Peeters, A.L.M. Verbeek, J.H.C.L. Hendriks, Roland Holland, M Mravunac   +4 more
openalex   +1 more source

Screening for colonic cancer in patients with Barrett's oesophagus. [PDF]

, 1989
Duncan A. Robertson, R C Ayres, C. Smith
openalex   +1 more source

Loss of primary cilia promotes EphA2‐mediated endothelial‐to‐mesenchymal transition in the ovarian tumor microenvironment

Molecular Oncology, EarlyView.
Loss of primary cilia in endothelial cells promotes EndMT and vascular abnormalities in the ovarian tumor microenvironment through EphA2 activation. Using human samples, in vitro models, and endothelial‐specific Kif3a‐knockout mice, we show that primary cilia loss drives the acquisition of cancer‐associated fibroblast‐like phenotypes, thereby ...
Jin Gu Cho, Yubin Hah, Eunsik Yun, Hye In Ka, Aram Lee, Sora Han, Dawn Lee, Sung Wook Kim, Jong Hoon Park, Byung Su Kwon, Young Yang, Jongmin Kim   +11 more
wiley   +1 more source

Effectiveness of early cancer screening and diagnosis in urban China. [PDF]

Sci Rep
Liu Y, Rui Y, Zhao Z, Zhang Y, Luo L, Wu L, Wei Q.   +6 more
europepmc   +1 more source

Screening for cervical cancer, 1973-1976.

, 1981
Gerry E. Hendershot
openalex   +2 more sources

Cancer screening degrees of proof and practical application [PDF]

, 1988
Barbara S. Hulka
openalex   +1 more source

Genomics‐led approach to drug testing in models of undifferentiated pleomorphic sarcoma

Molecular Oncology, EarlyView.
GA text Genomic data from undifferentiated pleomorphic sarcoma patients and preclinical models were used to inform a targeted drug screen. Selected compounds were tested in 2D and 3D cultures of UPS cell lines. A combination of trametinib and infigratinib was synergistic in the majority of UPS cell lines tested, which was further confirmed in an ex ...
Piotr J. Manasterski, Molly R. Danks, John P. Thomson, Morwenna Muir, Martin Lee, John C. Dawson, Ana T. Amaral, Juan Diaz‐Martin, David S. Moura, Javier Martin‐Broto, Ali Alsaadi, Donald M. Salter, Ailsa J. Oswald, Graeme Grimes, Larry Hayward, Ted R. Hupp, Karen Sisley, Paul H. Huang, Neil O. Carragher, Valerie G. Brunton   +19 more
wiley   +1 more source

Cervical cancer screening uptake in Côte d'Ivoire: Analysis of prevalence and associated factors. [PDF]

BMC Public Health
Adzigbli LA, Dowou RK, Gbordzoe NI, Mensah T, Arwill G, Aboagye RG, Baiden F.   +6 more
europepmc   +1 more source